Quality Assurance for AI
GISKARD is developing an open-source SaaS platform for automated AI quality testing to address ethical biases and prediction errors, aiming to lead in compliance with the EU AI Act.
Projectdetails
Introduction
The adoption of AI technology is growing faster than ever, tripling from 2017 to 2021 (McKinsey). Risks of AI incidents, in particular with ethical biases, prediction errors, and cybersecurity, are rising.
Current Challenges
Current AI quality tools are insufficient and rely on manual testing, leaving a gap that AI/ML engineers cannot meet in terms of workload, costs, and demand at the needed pace.
Proposed Solution
To address this need, GISKARD is developing an open-source and SaaS solution for companies that need quality assurance of their AI models. It provides a software platform for automated AI Quality Testing, Inspection, and Remediation.
Commitment to Standards
As a member of AFNOR, the French national standards council, GISKARD is committed to becoming the leading European software provider to help organisations prepare for the upcoming EU AI Act.
Support and Development
EIC support is crucially needed to achieve this. In this project, GISKARD will optimise and validate its AI Testing solution and extend it to more use cases such as:
- Time Series
- Computer Vision
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 2.499.999 |
Totale projectbegroting | € 3.729.395 |
Tijdlijn
Startdatum | 1-9-2023 |
Einddatum | 31-8-2025 |
Subsidiejaar | 2023 |
Partners & Locaties
Projectpartners
- GISKARD AIpenvoerder
Land(en)
Vergelijkbare projecten binnen EIC Accelerator
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
A new cardioprotective drug for acute treatment of myocardial infarctionResoTher aims to validate RTP-026, an immunomodulating therapy, to reduce heart damage and HF risk post-myocardial infarction through Phase II clinical studies. | EIC Accelerator | € 2.499.999 | 2024 | Details |
Clear, scalable and scientific framework to measure terrestrial biodiversity3Bee leverages IoT, wildlife monitoring, and satellite data to measure and regenerate biodiversity, generating certified Biodiversity Credits for corporations to enhance ESG reporting and brand value. | EIC Accelerator | € 2.252.714 | 2024 | Details |
Novel and Scalable microbial products for REgenerative agricultureN-Spire aims to revolutionize agriculture by creating a sustainable bioactive fertilizer through innovative manufacturing techniques, enhancing soil health and reducing chemical dependency. | EIC Accelerator | € 2.499.999 | 2024 | Details |
Quantum-based Randomness Processing Units (RPUs) for High-Performance Computation and Data SecurityQuside's Randomness Processing Unit (RPU) accelerates stochastic HPC and PQ cryptography by optimizing random workloads, enhancing efficiency and performance across various sectors. | EIC Accelerator | € 2.499.999 | 2024 | Details |
A new cardioprotective drug for acute treatment of myocardial infarction
ResoTher aims to validate RTP-026, an immunomodulating therapy, to reduce heart damage and HF risk post-myocardial infarction through Phase II clinical studies.
Clear, scalable and scientific framework to measure terrestrial biodiversity
3Bee leverages IoT, wildlife monitoring, and satellite data to measure and regenerate biodiversity, generating certified Biodiversity Credits for corporations to enhance ESG reporting and brand value.
Novel and Scalable microbial products for REgenerative agriculture
N-Spire aims to revolutionize agriculture by creating a sustainable bioactive fertilizer through innovative manufacturing techniques, enhancing soil health and reducing chemical dependency.
Quantum-based Randomness Processing Units (RPUs) for High-Performance Computation and Data Security
Quside's Randomness Processing Unit (RPU) accelerates stochastic HPC and PQ cryptography by optimizing random workloads, enhancing efficiency and performance across various sectors.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Developing Bias Auditing and Mitigation Tools for Self-Assessment of AI Conformity with the EU AI Act through Statistical MatchingAct.AI aims to enhance AI fairness and compliance with the EU AI Act by providing a versatile, plug-and-play tool for continuous bias monitoring across various data types and industries. | ERC POC | € 150.000 | 2024 | Details |
POTENTaiLIZERHet project onderzoekt de haalbaarheid van een AI-product, POTENTaiLIZER, om MKB-bedrijven te ondersteunen bij het optimaliseren van hun bedrijfsvoering via data-analyse en strategische tips. | MIT Haalbaarheid | € 20.000 | 2023 | Details |
AIQHet project onderzoekt hoe de bruikbaarheid van openbare datasets voor AI-training automatisch kan worden beoordeeld om kwaliteitsinzicht te verbeteren. | MIT Haalbaarheid | € 20.000 | 2022 | Details |
GIFT Generic Image and document Forensics ToolkitGIFT ontwikkelt een AI-gestuurde toolkit voor document- en beeldforensische analyses om manipulatie en fraude te detecteren, met focus op schaalbaarheid en gebruiksvriendelijkheid. | MIT R&D Samenwerking | € 193.600 | 2021 | Details |
Developing Bias Auditing and Mitigation Tools for Self-Assessment of AI Conformity with the EU AI Act through Statistical Matching
Act.AI aims to enhance AI fairness and compliance with the EU AI Act by providing a versatile, plug-and-play tool for continuous bias monitoring across various data types and industries.
POTENTaiLIZER
Het project onderzoekt de haalbaarheid van een AI-product, POTENTaiLIZER, om MKB-bedrijven te ondersteunen bij het optimaliseren van hun bedrijfsvoering via data-analyse en strategische tips.
AIQ
Het project onderzoekt hoe de bruikbaarheid van openbare datasets voor AI-training automatisch kan worden beoordeeld om kwaliteitsinzicht te verbeteren.
GIFT Generic Image and document Forensics Toolkit
GIFT ontwikkelt een AI-gestuurde toolkit voor document- en beeldforensische analyses om manipulatie en fraude te detecteren, met focus op schaalbaarheid en gebruiksvriendelijkheid.